Effect of Covid-19 on Caregivers of Persons with Dementia
Covid-19 对痴呆症患者照顾者的影响
基本信息
- 批准号:10220410
- 负责人:
- 金额:$ 44.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgitationAlzheimer&aposs DiseaseAlzheimer&aposs disease caregiverAlzheimer&aposs disease patientAssisted Living FacilitiesBehaviorBehavioralCOVID-19COVID-19 pandemicCaregiver BurdenCaregiversCaringCommunicable DiseasesCommunitiesContinuity of Patient CareDeath RateDecision MakingDementiaDronabinolElderlyEmploymentFamilyFamily CaregiverFamily RelationshipFibrinogenFormal caregiverGoalsGuidelinesHealthHealthcareHealthcare SystemsHomeInfection ControlInstitutesInterviewLong-Term CareMethodsMorbidity - disease rateNatureNursing HomesOutpatientsPatient CarePatientsPersonal SatisfactionPersonsProceduresQuarantineRandomized Controlled TrialsRoleSeveritiesShelter facilityStressStructureTimeVaccinesWorkbehavior changecaregivingexperienceinfection riskinformal caregivermortalitypandemic diseaserisk mitigationstressor
项目摘要
The US and its healthcare systems are experiencing an unprecedented crisis through the
COVID-19 pandemic that is having a major impact on PWD, their family caregivers, and the
front- line professional staff who support them. In many communities, death rates from COVID-
19 disproportionately involve older adults and PWD, especially those living in assisted living
facilities and nursing homes. Health workers in these facilities, and caring for older adults at
home, are also at risk of infection, morbidity and even mortality.Infection control guidelines and
mandates have shut down institutional access to visitors and instituted quarantining procedures
that further isolate PWD. Lack of structured activities, sheltering in place, caregiver stressors
around employment, finances, and risk mitigation all have the potential to exacerbate behavioral
issues in PWD. The nature of the pandemic also creates the need for urgent, real-time decision-
making, in the face of an evolving infectious disease that is highly communicable, leads to
unpredictable and precipitous declines and for which there is no cure or vaccine.
Specific Aims:
The goal of this study is to engage family and professional (CNAs,LPNs, RNs) caregivers of
PWD across the care continuum (nursing homes, assisted living facilities, and in the community)
to study the impact of COVID-19 on the health and well-being of PWD and their caregivers, the
caregiving experience and the impact of COVID-19 on patient behaviors and work/family
relationships. Through a mixed-methods study involving 600 formal and informal caregivers of
PWD residing in the community, in assisted living facilities (ALF) and nursing homes, we will
accomplish this goal through the following aims:
Aim 1: Describe the caregiver lived experience during the COVID-19 pandemic
Aim 2: Examine how COVID-19 related factors (including quarantining, isolation, etc.) have
affected caregiver stress.
Aim 3: Explore the role of COVD-19 related factors (i.e., PPE, caregiver stress) on behavior
changes and severity in PWD.
Aim 4: Assess the impact of COVID-19 on caregiver planning and health care decision-making
美国及其医疗体系正在经历一场前所未有的危机
新冠肺炎大流行,对残疾患者、他们的家庭照顾者和
支持他们的一线专业工作人员。在许多社区,COVID的死亡率-
19不成比例地涉及老年人和残疾人,特别是那些生活在辅助生活中的人
设施和养老院。这些设施中的卫生工作者,并在
也有感染、发病甚至死亡的风险。感染控制指南和
命令已经关闭了机构对访客的准入,并建立了隔离程序
这进一步隔离了PWD。缺乏有组织的活动、适当的庇护、照顾者的压力来源
围绕就业、财务和风险缓解,都有可能加剧行为
PWD中的问题。大流行的性质也产生了对紧急、实时决策的需求。
面对一种高度传染性的不断演变的传染病,导致
不可预测的急剧下降,而且没有治愈方法或疫苗。
具体目标:
本研究的目标是让家庭和专业(CNA、LPN、RN)照顾者参与
护理连续体(养老院、辅助生活设施和社区)中的残障人士
为研究新冠肺炎对残疾人士及其照顾者健康福祉的影响,
护理体验及新冠肺炎对患者行为和工作/家庭的影响
两性关系。通过一项包括600名正式和非正式照顾者的混合方法研究
残疾人士居住在社区、辅助生活设施和护养院,我们会
通过以下目标实现这一目标:
目标1:描述新冠肺炎疫情期间照顾者的生活经历
目标2:检查新冠肺炎相关因素(包括隔离、隔离等)有
受影响的照顾者压力。
目的3:探讨COVD-19相关因素(PPE、照顾者压力)对行为的影响
PWD的变化和严重程度。
目标4:评估新冠肺炎对照顾者规划和医疗决策的影响
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cannabinoids for Agitation in Alzheimer's Disease.
- DOI:10.1016/j.jagp.2021.01.015
- 发表时间:2021-12
- 期刊:
- 影响因子:0
- 作者:Outen JD;Burhanullah MH;Vandrey R;Amjad H;Harper DG;Patrick RE;May RL;Agronin ME;Forester BP;Rosenberg PB
- 通讯作者:Rosenberg PB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent Peter Forester其他文献
Brent Peter Forester的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brent Peter Forester', 18)}}的其他基金
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10411985 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10224086 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
9788999 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
10170190 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9104639 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9706077 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8016112 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8424297 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8214530 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
7582632 - 财政年份:2009
- 资助金额:
$ 44.63万 - 项目类别:
相似海外基金
Relationship between Biomarkers of Oxidative Stress and Agitation Severity in Moderate-to-severe Alzheimer's Disease
中重度阿尔茨海默病氧化应激生物标志物与躁动严重程度之间的关系
- 批准号:
497994 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Effects of dexmedetomidine on agitation in critically ill TBI patients - DEX-TBI
右美托咪定对危重 TBI 患者躁动的影响 - DEX-TBI
- 批准号:
488402 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Operating Grants
Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia
共同设计和评估传感器仪表“智能袜子”(MPATIX),以改善痴呆症患者的痛苦和躁动管理
- 批准号:
10055596 - 财政年份:2023
- 资助金额:
$ 44.63万 - 项目类别:
Collaborative R&D
Identifying pre-agitation biometric signature in dementia patients: A feasibility study
识别痴呆症患者的躁动前生物识别特征:可行性研究
- 批准号:
486612 - 财政年份:2022
- 资助金额:
$ 44.63万 - 项目类别:
Studentship Programs
Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
- 批准号:
486589 - 财政年份:2022
- 资助金额:
$ 44.63万 - 项目类别:
Studentship Programs
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10404523 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10683499 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Development of Memesto, a wearable repetitive message and music therapy device that senses and reduces agitation in persons with AD/ADRD.
开发 Memesto,一种可穿戴式重复信息和音乐治疗设备,可感知并减少 AD/ADRD 患者的躁动。
- 批准号:
10322846 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10190522 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10365272 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:














{{item.name}}会员




